Adamis Pharmaceuticals Gross Profit 2006-2019 | ADMP

Adamis Pharmaceuticals gross profit from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Adamis Pharmaceuticals Annual Gross Profit
(Millions of US $)
2018 $5
2017 $6
2016 $2
2015 $
2014 $
2014 $
2013 $
2012 $
2011 $
2010 $0
2009 $0
2008 $
2007 $
2006 $2
2005 $12
Adamis Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
Q2 2019 $2
Q1 2019 $1
Q4 2018 $1
Q3 2018 $2
Q2 2018 $2
Q1 2018 $1
Q4 2017 $1
Q3 2017 $1
Q2 2017 $2
Q1 2017 $1
Q4 2016 $1
Q3 2016 $0
Q2 2016 $1
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006 $0
Q3 2006 $0
Q2 2006 $1
Q1 2006 $1
Q4 2005 $1
Q3 2005 $2
Q2 2005 $8
Q1 2005 $2
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.033B $0.015B
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.185B 37.68
Takeda Pharmaceutical (TAK) Japan $54.082B 8.46
Astellas Pharma (ALPMY) Japan $31.284B 14.91
Merck (MKGAF) Germany $15.108B 20.62
Eisai (ESALY) Japan $14.701B 22.50
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.301B 18.25
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
IPSEN SA ADR (IPSEY) France $8.872B 0.00
Neurocrine Biosciences (NBIX) United States $8.771B 0.00
Ionis Pharmaceuticals (IONS) United States $7.839B 16.91
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.228B 0.00
Catalent (CTLT) United States $7.112B 28.11
Jazz Pharmaceuticals (JAZZ) Ireland $6.775B 8.92
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.094B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Hypermarcas (HYPMY) Brazil $5.298B 19.05
Orion OYJ (ORINY) Finland $5.271B 27.14
United Therapeutics (UTHR) United States $3.602B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.409B 78.15
FibroGen (FGEN) United States $3.372B 84.35
Evotec AG (EVTCY) Germany $3.224B 44.14
Nektar Therapeutics (NKTR) United States $3.027B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.918B 10.46
PTC Therapeutics (PTCT) United States $2.233B 0.00
Tilray (TLRY) Canada $2.087B 0.00
Xencor (XNCR) United States $1.986B 43.31
Zogenix (ZGNX) United States $1.884B 0.00
Portola Pharmaceuticals (PTLA) United States $1.866B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.618B 58.86
Corcept Therapeutics (CORT) United States $1.558B 21.41
USANA Health Sciences (USNA) United States $1.550B 15.55
Heron Therapeutics (HRTX) United States $1.472B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.368B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.260B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.175B 19.39
Endo (ENDP) Ireland $1.104B 1.94
ArQule (ARQL) United States $1.098B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.957B 0.00
Aerie Pharmaceuticals (AERI) United States $0.942B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.906B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.894B 3.99
TherapeuticsMD (TXMD) United States $0.884B 0.00
Dova Pharmaceuticals (DOVA) United States $0.808B 0.00
Organogenesis Holdings (ORGO) United States $0.676B 0.00
Karyopharm Therapeutics (KPTI) United States $0.663B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.540B 0.00
Indivior (INVVY) United States $0.501B 1.81
Akebia Therapeutics (AKBA) United States $0.494B 0.00
Lannett Co Inc (LCI) United States $0.474B 4.99
Aptorum Group (APM) Hong Kong, SAR China $0.458B 0.00
ChemoCentryx (CCXI) United States $0.449B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.444B 0.00
Siga Technologies (SIGA) United States $0.437B 1.02
Translate Bio (TBIO) United States $0.425B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.397B 0.00
Dermira (DERM) United States $0.389B 0.00
Collegium Pharmaceutical (COLL) United States $0.387B 0.00
DURECT (DRRX) United States $0.382B 0.00
ImmunoGen (IMGN) United States $0.362B 0.00
Innate Pharma SA (IPHYF) France $0.361B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.358B 16.26
Corbus Pharmaceuticals Holdings (CRBP) United States $0.323B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
OptiNose (OPTN) United States $0.309B 0.00
Molecular Templates (MTEM) United States $0.290B 0.00
Ardelyx (ARDX) United States $0.284B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.274B 0.00
Recro Pharma (REPH) United States $0.273B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.243B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.229B 0.00
CV Sciences (CVSI) United States $0.216B 0.00
KalVista Pharmaceuticals (KALV) United States $0.212B 0.00
GlycoMimetics (GLYC) United States $0.202B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.193B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.190B 0.00
CannTrust Holdings (CTST) Canada $0.187B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 30.03
AcelRx Pharmaceuticals (ACRX) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.162B 0.00
IMV INC (IMV) Canada $0.152B 0.00
Concert Pharmaceuticals (CNCE) United States $0.145B 0.00
Calithera Biosciences (CALA) United States $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.139B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.134B 0.00
MEI Pharma (MEIP) United States $0.127B 0.00
Generex Biotechnology (GNBT) United States $0.127B 0.00
Jounce Therapeutics (JNCE) United States $0.115B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.112B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.59
Aquestive Therapeutics (AQST) United States $0.084B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Lipocine (LPCN) United States $0.077B 0.00
MediWound (MDWD) Israel $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Majesco Entertainment (PTE) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.069B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 9.87
SCYNEXIS (SCYX) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.061B 0.00
Novan (NOVN) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.050B 0.00
CTI BioPharma (CTIC) United States $0.048B 0.00
Capnia (SLNO) United States $0.047B 0.00
Iterum Therapeutics (ITRM) Ireland $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00